| Application no. and date | 02701122.0 (espacenet) (Federated) (European Patent Register), 20020219 | | Patent/reg. no. and date | DK/EP 1361884, 20110720 | | Publication date | 20031119 | | Priority no. and date | US 270363 P, 20010220 | | EP pub. no. and date |
EP 1361884 20031119 | | Effective date | | | Applicant/owner | Oncolytics Biotech Inc., Suite 210
1167 Kensington Crescent N. W.
Calgary, AB T2N 1X7, CA | | Applicant ref. no. | 142276 | | Inventor | COFFEY, Matthew, C., 2231 Bowness Road, N.W.
Calgary, Alberta T2N 3L4, CA,
THOMPSON, Bradley, G., 1775 - 7th Avenue N.W.
Calgary, Alberta T2N 0Z5, CA | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 35/76 (2006.01) , A61P 35/00 (2006.01) | | Title | Sensibilisering af neoplastiske celler, der er resistente over for kemoterapeutisk middel, med reovirus | | Int. application no. | CA2002000201 | | Int. publication no. | WO2002066040 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
